Double-targeting using a TrkC ligand conjugated to dipyrrometheneboron difluoride (BODIPY) based photodynamic therapy (PDT) agent.
Double-targeting using a TrkC ligand conjugated to dipyrrometheneboron difluoride (BODIPY) based photodynamic therapy (PDT) agent.
复制标题
DOI:
10.1021/jm4012142
复制
发表时间:
2013-10-10
影响因子:
7.3
通讯作者:
Burgess K
中科院分区:
文献类型:
--
作者:
Kamkaew A;Burgess K
A molecule 1 (IY-IY-PDT) was designed to contain a fragment (IY-IY) that targets the TrkC receptor, and a photosensitizer that acts as an agent for photodynamic therapy (PDT). Molecule 1 had sub-micromolar photocytotoxicities to cells that were either engineered to stably express TrkC (NIH3T3-TrkC) or that naturally express high levels of TrkC (SY5Y neuroblastoma lines). Control experiments showed 1 is not cytotoxic in the dark, and has significantly less photocytotoxicity towards cells that do not express TrkC (NIH3T3-WT). Other controls featuring a similar agent 2 (YI-YI-PDT) which is identical and isomeric with 1 except that the targeting region is scrambled (a YI-YI motif, see text) showed 1 is considerably more photocytotoxic than 2 on TrkC+ cells. Imaging live TrkC+ cells after treatment with a fluorescent agent 1 (IY-IY-PDT) proved that 1 permeates into TrkC+ cells and localizes in the lysosomes. This observation indirectly indicates agent 1 enters the cells via the TrkC receptor. Consistent with this, the dose-dependent PDT effects of 1 can be competitively reduced by the natural TrkC ligand, neurotrophin NT3.
登录
查看更多内容
影响因子:
8.8
作者:
通讯作者:
--
影响因子:
46.2
作者:
Kamkaew A;Lim SH;Lee HB;Kiew LV;Chung LY;Burgess K
通讯作者:
Burgess K
影响因子:
4
作者:
Chen, Dianjun;Brahimi, Fouad;Burgess, Kevin
通讯作者:
Burgess, Kevin
影响因子:
78.5
作者:
Chabner, BA;Roberts, TG
通讯作者:
Roberts, TG
影响因子:
2.9
作者:
Batat, Pinar;Cantuel, Martine;McClenaghan, Nathan D.
通讯作者:
McClenaghan, Nathan D.